Sleeve Gastrectomy Segment by Application to Account Larger Share in Bariatric Surgeries Market during 2022–2030.

According to our new research study on "Bariatric Surgeries Market Forecast to 2030 –Global Analysis – by type and end user," the market was valued at US$ 8546.66 million in 2022; and is expected to reach US$ 27647.38 million by 2030 and it estimated to grow at a rate of 15.8% from 2022 to 2030. The report highlights trends prevailing in the market, and factors driving and hindering the bariatric surgeries market growth.

The bariatric surgeries market growth is due to the increasing prevalence of obesity and growing demand for minimally invasive surgeries. Whereas stringent regulatory policies and increase in safety is hindering the market growth.

The bariatric surgeries market, by type, is segmented into adjustable gastric bands (AGB), sleeve gastrectomy, gastric bypass, biliopancreatic diversion with duodenal switch (BPD-DS), and others. In 2022, the sleeve gastrectomy segment held the largest market share, and the gastric bypass segment is estimated to register the fastest CAGR during 2022–2030. In sleeve gastrectomy, the stomach is divided and stapled vertically by removing more than 85% of stomach, forming a banana-shaped pouch or tube limiting the amount of food ingested and absorbed by the body. In this surgery, most of the stomach is removed, lowering levels of the hormone ghrelin, which is responsible for appetite, along with limiting food intake and its absorption. Risks of sleeve gastrectomy include heartburn, stomach ulcers, gastritis, injury to the intestines, stomach, or other organs during surgery, and vomiting. Also, poor nutrition and scarring inside the belly could lead to a future blockage in the bowel.

North America holds the largest share of the bariatric surgeries market. The market in this region is split into the US, Canada, and Mexico. The market growth in the region is attributed to the increasing burden of obesity, rising government initiatives to curb obesity, and a surging number of mergers, collaborations, and partnerships among market players. In addition, the significantly growing prevalence of diabetes is propelling the demand for bariatric surgeries. The increasing burden of obesity and the growing prevalence of diabetes primarily drive the US bariatric surgery market. The demand for bariatric surgeries has increased remarkably over the past few years to reduce the burden of various chronic diseases. According to the World Obesity Atlas 2022, the estimated number of adults with BMI ≥30kg/m2 in the US by 2030 is as follows:

ADULT OBESITY IN 2030

CHILD OBESITY IN 2030

Thus, populations with high BMIs in the US are more likely to undergo bariatric surgeries to avoid complications associated with diabetes and heart diseases.

According to the data published by the American Society for Metabolic & Bariatric Surgery in June 2022, the estimated number of bariatric surgeries performed in 2021 is as follows:

Bariatric surgeries in the US have grown significantly owing to advancements in technologies such as gastric bands & balloons and other surgical procedures mentioned above.

Several market players are adopting organic strategies to stay competitive in the market. For instance, in May 2021, Standard Bariatrics announced that it had been cleared by the US Food and Drug Administration (FDA) for its novel Titan SGS stapling technology, designed precisely for bariatric sleeve surgery.

Intuitive Surgical Inc, Integra LifeSciences Holdings Corp, Apollo Endosurgery Inc, Conmed Corp, Medtronic Plc, Ethicon USA LLC, Olympus Corp, Reshape Lifesciences Inc, Spatz FGIA Inc, Helioscopie SA are among the leading companies operating in the vital signs monitoring devices market.    

Companies operating in the bariatric surgeries market adopt various organic and inorganic strategies. Growth strategies mainly include product launches and product approvals, mergers & acquisitions, collaborations, and partnerships are among the growth strategies witnessed in the bariatric surgeries market.

A few of the significant developments by key market players are listed below.

Various initiatives taken by leading players operating in the bariatric surgeries market are listed below:

• In June 2021, Ethicon launched a new advanced bipolar energy device, the ENSEAL X1 Curved Jaw Tissue Sealer. It enhances procedural efficiency by providing stronger sealing and greater access to more tissue than LigaSure Maryland. The device is used for colorectal, gynecological, bariatric, and thoracic surgeries.
• In November 2022, Boston Scientific Corporation acquired Apollo Endosurgery Inc. with a total value of ~US$ 615 million, which indicated a cash price of US$ 10 per share. The Apollo Endosurgery product portfolio includes devices used during endoluminal surgery (ELS) procedures to close and manage gastrointestinal defects and complications and aid in weight loss for patients with obesity.
• In September 2022, Allurion Technologies, a US-based medical device maker, launched its weight loss solution, a swallowable gastric balloon, in India. Allurion balloon—which had received approval from the Central Drugs Standard Control Organization (CDSCO)—claims to reduce a person's body weight by 10–15% on average in just 16 weeks.
• In August 2022, Teleflex acquired Standard Bariatrics and its powered stapling technology for bariatric surgery for US$ 170 million in cash up front, with the potential for up to $ 130 million in additional payments after passing certain commercial milestones. The acquisition of Standard Bariatrics provides an innovative product for the large and growing sleeve gastrectomy market, which is estimated to be ~120,000 procedures annually in the US.
• In May 2023, Olympus launched POWERSEALTM Sealer/Divider for the Middle East & Africa (MEA) and Europe. This multifunctional advanced bipolar device supports surgeons across multiple medical specialties with dissection, state-of-the-art sealing, and grasping capabilities for open and laparoscopic surgical treatments such as colorectal resection, bariatric surgery, colorectal resection, and total laparoscopic hysterectomy.
• In September 2021, Olympus acquired the new advanced bipolar surgical energy product range, POWERSEAL. The POWERSEAL 5 mm Curved Jaw Tissue Sealer and Divider is a double-action device that meets the highest standards of medical performance for advanced bipolar surgical energy devices by delivering constant sealing reliability in an ergonomic and multifunctional design that promotes procedural efficiency. The POWERSEAL devices can be employed in numerous surgical procedures, including general, gynecological, colorectal, bariatric, urological, thoracic, and vascular surgical procedures.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com